A wealth of information is being made available in an interactive format which will give a much clearer and more precise overview in one single place of how the Medical Device and IVD Regulations are being implemented than has previously been possible.
An exciting new dashboard collating invaluable insights into the efficiency of the EU’s medtech regulations and monitoring the availability of devices in EU is now live.
It is at the early stages of being populated but currently features historic notified body data giving a valuable overview...
In revising the foundations of EU product legislation, the European Commission aims to increase harmonization, cut regulatory burdens and promote digital tools to boost compliance and safety.
Steve Bates, head of the UK BioIndustry Association, has been appointed executive chair of the government’s Office for Life Sciences as the UK restructures its life sciences approach and drives health outcomes with a new NHS Long-Term Care plan.
The UK government’s response to MHRA public consultation on risk proportionate device routes to market and physical UKCA markings adds momentum to drive for modern, agile system. Another consultation in late 2025 will propose indefinite recognition of CE-marked devices in Great Britain.
The EU’s extra layer of checks on clinical evidence is proving a difficult, and sometimes humiliating process, for many device companies whose products have come under the spotlight.
